DuPont de Nemours Inc. (DuPont (DD)) shares slipped Tuesday even after the company posted second-quarter results that beat expectations and lifted its full-year earnings outlook. Sometimes good news isn't enough, especially when investors are busy squinting at the fine print.

The chemical giant reported adjusted earnings of $1.88 per share, up 48% from a year ago and comfortably ahead of the $1.76 analysts were looking for. Net sales climbed 4% to $1.819 billion, also topping the $1.813 billion consensus, with organic sales growing at the same clip. But the stock traded down about 0.5% as the market digested a narrowed sales forecast and currency headwinds that could take some shine off the improved earnings picture.

Earnings And Margins

On a GAAP basis, diluted EPS from continuing operations jumped to $1.37 from 17 cents, while GAAP income from continuing operations rose to $191 million from $24 million. Operating EBITDA increased 6% to $448 million, helped by organic growth and productivity gains. The operating EBITDA margin expanded 40 basis points to 24.6%.

Healthcare And Water Technologies

In the Healthcare & Water Technologies segment, sales rose 5% to $856 million, with organic growth of 4%. Operating EBITDA increased 4% to $258 million, though margin slipped 30 basis points to 30.1%.

Healthcare Technologies sales reached $473 million, driven by double-digit growth in personal protection and biopharma. Water Technologies sales came in at $383 million, supported by industrial water and semiconductor demand, though weakness in the Middle East partially offset those gains.

Diversified Industrials And Operations

The Diversified Industrials segment saw sales rise 3% to $963 million, with operating EBITDA up 7% to $213 million. Margin expanded 70 basis points to 22.1%. Industrial Technologies sales hit $538 million, led by aerospace and electric-vehicle battery applications, while Building Technologies sales totaled $425 million, buoyed by construction growth.

DuPont also highlighted some operational wins: it launched about 50 AI-supported sales plays, won roughly 150 opportunities, and posted an approximately 30% win rate. Operational initiatives delivered more than 100 basis points of net productivity improvement and gains in on-time, in-full metrics.

Operating cash flow came in at $400 million, with transaction-adjusted free cash flow of $326 million and a 127% conversion rate. The company ended the quarter with $1.74 billion in cash and $3.13 billion in long-term debt. It plans to repurchase $250 million of shares in the third quarter.

Raised 2026 Outlook

Looking ahead, DuPont raised its full-year adjusted EPS guidance to $7.17-$7.32, up from $7.02-$7.16, and above the $7.13 consensus. However, it narrowed its sales guidance to $7.160 billion-$7.190 billion from $7.155 billion-$7.215 billion, versus the $7.164 billion estimate. The company expects organic sales growth slightly above 4%, including about 6% growth in the second half, despite currency headwinds. It also raised the operating EBITDA midpoint by $15 million to about $1.76 billion.

Conference Call

During the earnings call, DuPont said it completed a reverse stock split, aligning its classification to 'Industrial' under GICS. For the third quarter, the company projects adjusted EPS between $1.80 and $1.90, below the $1.93 estimate, and sales of $1.835 billion, lower than the $1.877 billion consensus.

DuPont also said it continues to explore M&A opportunities, particularly in water and healthcare, while maintaining a disciplined capital allocation strategy. The company is optimizing productivity and efficiency through initiatives like the 80/20 rule, aiming for better yield and asset utilization.

At the time of publication, DuPont shares were down 0.54% at $140.52.